Sterling Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $382K | Buy |
15,965
+410
| +3% | +$9.8K | 0.01% | 1048 |
|
|
2025
Q1 | $387K | Buy |
15,555
+14,192
| +1,041% | +$353K | 0.01% | 967 |
|
|
2024
Q4 | $25.7K | Buy |
1,363
+1,208
| +779% | +$22.8K | ﹤0.01% | 1801 |
|
|
2024
Q3 | $2.33K | Buy |
+155
| New | +$2.33K | ﹤0.01% | 2119 |
|
|
2015
Q4 | – | Sell |
-7,545
| Closed | -$310K | – | 1021 |
|
|
2015
Q3 | $310K | Buy |
+7,545
| New | +$310K | ﹤0.01% | 860 |
|
|
2015
Q1 | – | Sell |
-2,949
| Closed | -$261K | – | 941 |
|
|
2014
Q4 | $261K | Buy |
2,949
+79
| +3% | +$6.99K | ﹤0.01% | 858 |
|
|
2014
Q3 | $278K | Buy |
+2,870
| New | +$278K | ﹤0.01% | 827 |
|